AdaptHealth (AHCO) Divestments (2025)

AdaptHealth's (AHCO) quarterly Divestments came in at $3.2 million in Q4 2025, up 116.19% quarter-over-quarter from $1.5 million in Q3 2025.

AdaptHealth (AHCO) Divestments (2025) Analysis & Trends

AdaptHealth's Divestments history runs 1 years deep, the most recent figure standing at $3.2 million for Q4 2025.

  • On a quarterly basis, Divestments changed N/A year-over-year to $3.2 million in Q4 2025; TTM through Dec 2025 was $4.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $120.4 million, changed N/A from the prior year.
  • Divestments rose to $3.2 million in Q4 2025 per AHCO's latest filing, from $1.5 million in the prior quarter.
  • Across five years, Divestments topped out at $3.2 million in Q4 2025 and bottomed at $1.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn -
2 Stryker 129.08 Bn 126.21 Bn 3.81 Bn -
3 Medtronic 108.57 Bn 99.35 Bn 6.41 Bn -
4 Boston Scientific 68.52 Bn 67.07 Bn 3.61 Bn -
5 Edwards Lifesciences 48.35 Bn 44.68 Bn 1.29 Bn -
6 Dexcom 28.35 Bn 27.24 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.17 Bn 25.88 Bn 1.98 Bn -
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 24.37 Bn 21.25 Bn 2.07 Bn 9.37 Mn
10 AdaptHealth 1.51 Bn 1.46 Bn 111.50 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.25 Mn
Sep 30, 2025 1.50 Mn